AI Insight
Alyssa Tapley, a 13-year-old with treatment-resistant leukemia, became the first person to have their life saved through CRISPR base editing technology. After conventional treatments failed and she was given weeks to live, she received an experimental therapy that successfully treated her cancer. This represents the first documented case of base editing - a precise form of gene editing that changes individual DNA letters - being used to save a human life.
Why it matters
This case demonstrates that advanced gene editing techniques can provide treatment options for patients with otherwise fatal diseases when standard therapies fail. The success opens possibilities for treating other genetic diseases and cancers that are resistant to conventional medical interventions.
Understand the Science
When standard leukaemia treatments failed, 13-year-old Alyssa Tapley was told she had only weeks left – but then she was offered an experimental procedure
Source: I’m the first person whose life was saved by CRISPR base editing